Brain Imaging in Early Psychosis
NCT03932188 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2020-11-25
Summary
This study assesses brain connectivity and function of individuals ages 13-25 at a prodromal or early stage of a psychotic disorder. Participation involves approximately 3 hours of MRI scanning and up to 6 hours of behavioral testing at Washington University School of Medicine's campus.
Conditions
- Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)
Interventions
- BEHAVIORAL
-
Mental Health Assessments and Computerized Cognitive Test
Participants will be asked to complete questionnaires and will be asked questions that address a broad range of personal life experiences involving social, occupational, domestic, and other behaviors.
- DEVICE
-
MRI scan
Up to two MRI scan sessions will be done, altogether totaling just under 3 hours of scanning. MR scanners measure brain anatomy and activity using very strong magnets. No X-rays or radiation are involved.
Sponsors & Collaborators
-
Washington University School of Medicine
lead OTHER
Eligibility
- Min Age
- 13 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2021-06-19
- Completion
- 2021-06-19
Countries
- United States
Study Locations
More Related Trials
-
Connectomics in Psychiatric Classification of Bipolar Disorder and Schizophrenia
NCT02756065 ·Status: COMPLETED
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Feasibility of an Early Detection Program for Early Psychosis on a College Campus
NCT03983421 ·Status: COMPLETED
-
A Multimodal Imaging Study of Dopamine in Early Psychosis
NCT06977308 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers
NCT00001284 ·Status: COMPLETED
-
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
NCT00942981 ·Status: COMPLETED
-
Childhood Trauma in Schizophrenia: Exploration of Links Between Gene Expression, Cerebral Morphology and Symptomatology
NCT03355781 ·Status: COMPLETED
-
Neuroplasticity in TBI and Schizophrenia
NCT03995368 ·Status: COMPLETED ·Phase: NA
-
Psychosis-Associated Neuroinflammation in Schizophrenia
NCT02009826 ·Status: COMPLETED
-
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
NCT01561859 ·Status: COMPLETED ·Phase: NA
-
Studies of Frontal Lobe Brain Functioning in Schizophrenia
NCT00001258 ·Status: COMPLETED
-
Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders
NCT07295652 ·Status: RECRUITING ·Phase: NA
-
Functional Magnetic Resonance Imaging Study in Schizophrenia Patients and Correlation With Cognitive Impairments
NCT06471179 ·Status: NOT_YET_RECRUITING
-
Brain Imaging, Attention, and Auditory Processing in Schizophrenia
NCT03068806 ·Status: COMPLETED
-
Enhancing the Prospective Prediction of Psychosis
NCT00291200 ·Status: COMPLETED
-
Psychosis: Early Detection, Intervention and Prevention
NCT01597141 ·Status: COMPLETED ·Phase: NA
-
Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study
NCT03442101 ·Status: ACTIVE_NOT_RECRUITING
-
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
NCT04218981 ·Status: COMPLETED ·Phase: NA
-
Cerebellar Modulation of Cognition in Psychosis
NCT06107764 ·Status: RECRUITING ·Phase: NA
-
Remote State Representation in Early Psychosis
NCT05538832 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis
NCT01688765 ·Status: COMPLETED
-
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
NCT05445180 ·Status: RECRUITING ·Phase: NA
-
Tracking Outcomes in Psychosis
NCT02882204 ·Status: UNKNOWN
-
Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis
NCT06542640 ·Status: RECRUITING ·Phase: NA
-
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
NCT07226895 ·Status: RECRUITING ·Phase: PHASE1/PHASE2